LIC-backed GSK Pharma declares ₹32 per share dividend, net profit down 89% YoY in Q4 | Mint
GlaxoSmithKline: Back To The Drawing Board (NYSE:GSK) | Seeking Alpha
Another Activist Investor Joins Calls For GSK Leadership Review :: Scrip
Glaxo (GSK) Q4 Earnings Lag Estimates, Shingrix Back on Track
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
Visualizing the World's Biggest Pharmaceutical Companies
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
GSK & AZN: 2 dividend-paying pharma stocks for income investors | Kalkine Media
Unveiling GSK PLC (GSK)'s Value: Is It Really Priced Right? A Comprehensive Guide
Biopharma: Market Cap, Meet Capital Investment | Site Selection Magazine
Business and Financial News - CNN Money
Who Are the GlaxoSmithKline PLC Leaders and Executives?
GSK Pharmaceuticals India: market share of therapy drugs 2022 | Statista
TOP 6 Largest FMCG Companies (Market... - Share News Today | Facebook
Glaxo Underperforms Industry in a Year: What's in Store?
Unilever Needs $10 Billion Bump to Win Glaxo Unit, Analysts Say - BNN Bloomberg
Glaxosmithkline plc - ADR Shares Close in on 52-Week High - Market Mover | Nasdaq
Elliott Publishes Letter on GlaxoSmithKline
 "GSK Pharma surges 7%, nears record high on healthy business outlook")
GSK Pharma surges 7%, nears record high on healthy business outlook
When is big pharma no longer big pharma? | Evaluate
GlaxoSmithKline (GSK) - Dividend Yield
Merck, Vertex and Lilly led biopharma share price gains in 2022
Investor sentiment surges for US companies, with European and APAC firms undervalued - Pharmaceutical Technology
Guest Post by Thecoinrepublic.com: GSK Plc (NYSE: GSK): Gsk Stock Ready For A Blast, Analysts Says? | CoinMarketCap
Top 25 Global Pharmaceutical Companies by Market Cap 2018 - Pharmaceutical Processing World
Biggest biopharma firms see market cap decline
Drug wars: how AstraZeneca overtook GSK in UK pharma
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
